| 11/30 | GALAPAGOS : reports positive topline results with GLPG1205 in IPF patients in PI.. | AQ |
| 11/30 | Galapagos reports positive topline results with GLPG1205 in IPF patients in P.. | GL |
| 11/23 | GALAPAGOS : Selvita to acquire Fidelta from Galapagos | AQ |
| 11/23 | GALAPAGOS : Selvita to acquire Fidelta from Galapagos | AQ |
| 11/09 | GALAPAGOS : First patient dosed with GLPG3667 in psoriasis patient Phase 1b tria.. | AQ |
| 11/09 | GALAPAGOS : First patient dosed with GLPG3667 in psoriasis patient Phase 1b tria.. | AQ |
| 11/09 | First patient dosed with GLPG3667 in psoriasis patient Phase 1b trial | GL |
| 11/09 | OXURION NV Confirms New Patents for THR-687 Issued by European and US Patent .. | AQ |
| 11/05 | GALAPAGOS : OncoArendi and Galapagos enter into exclusive collaboration on chiti.. | AQ |
| 11/05 | GALAPAGOS : OncoArendi and Galapagos enter into exclusive collaboration on chiti.. | AQ |
| 11/05 | OncoArendi and Galapagos enter into exclusive collaboration on chitinase inhi.. | GL |
| 11/05 | GALAPAGOS : reports Q3 2020 results | AQ |
| 11/05 | GALAPAGOS : reports Q3 2020 results | AQ |
| 11/05 | Galapagos reports Q3 2020 results | GL |
| 11/03 | GILEAD SCIENCES : European Medicines Agency Validates Marketing Application for .. | AQ |
| 11/02 | GALAPAGOS : European Medicines Agency Validates Marketing Application for Filgot.. | BU |
| 11/02 | GALAPAGOS : European medicines agency validates marketing application for .. | AQ |
| 11/02 | GALAPAGOS : European medicines agency validates marketing application for .. | AQ |
| 11/02 | European medicines agency validates marketing application for filgotin.. | GL |
| 10/27 | GALAPAGOS : rsquo; R&D Roundtable showcases Toledo program | AQ |
| 10/27 | GALAPAGOS : rsquo; R&D Roundtable showcases Toledo program | AQ |
| 10/27 | Galapagos' R&D Roundtable showcases Toledo program | GL |
| 10/16 | GALAPAGOS : And servier report topline results for roccella phase 2 clinical tri.. | AQ |
| 10/16 | Oxurion NV Business Update, Q3 2020 | AQ |
| 10/15 | GALAPAGOS : Servier Knee Osteoarthritis Trial Fails to Meet Primary, Secondary E.. | DJ |
| 10/15 | GALAPAGOS : and Servier report topline results for ROCCELLA Phase 2 clinical tri.. | AQ |
| 10/15 | GALAPAGOS : and Servier report topline results for ROCCELLA Phase 2 clinical tri.. | AQ |
| 10/15 | Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical tr.. | GL |
| 10/14 | Oxurion NV appoints Tom Graney, CFA as Chief Financial Officer | AQ |
| 10/13 | GILEAD SCIENCES INC. : - Phase 2b/3 Trial Shows Efficacy of Filgotinib for the I.. | AQ |
| 10/12 | GILEAD SCIENCES : Galapagos See Sustained Efficacy, Safety for Filgotinib | DJ |
| 10/12 | GALAPAGOS : Phase 2b/3 trial shows efficacy of filgotinib for the induction and .. | AQ |
| 10/12 | GALAPAGOS : Phase 2b/3 trial shows efficacy of filgotinib for the induction and .. | AQ |
| 10/12 | GALAPAGOS : Phase 2b/3 Trial Shows Efficacy of Filgotinib for the Induction and .. | BU |
| 10/12 | Phase 2b/3 trial shows efficacy of filgotinib for the induction and maintenan.. | GL |
| 10/09 | Invitation OXURION R&D Investor Day, Virtual 15 October 2020 at 5.30pm CET/ 1.. | AQ |
| 09/30 | GALAPAGOS : announces first dosing with Toledo compound GLPG3970 in psoriasis tr.. | AQ |
| 09/30 | Oxurion NV to Present New Pre-Clinical Data on THR-687 at EURETINA 2020 Virtu.. | AQ |
| 09/29 | GALAPAGOS : announces first dosing with Toledo compound GLPG3970 in psoriasis tr.. | AQ |
| 09/29 | GALAPAGOS : announces first dosing with Toledo compound GLPG3970 in psoriasis tr.. | AQ |
| 09/29 | Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis .. | GL |
| 09/28 | Gilead Sciences, Inc. - Jyseleca Approved in Japan for Rheumatoid Arthritis | AQ |
| 09/28 | GILEAD SCIENCES : European Commission Grants Marketing Authorization for Jyselec.. | AQ |
| 09/25 | GALAPAGOS : European commission grants marketing authorization for jyseleca®.. | AQ |
| 09/25 | GALAPAGOS : European commission grants marketing authorization for jyseleca®.. | AQ |
| 09/25 | GALAPAGOS : European Commission Grants Marketing Authorization for Jyseleca® .. | BU |
| 09/25 | European commission grants marketing authorization for jyseleca® (filgoti.. | GL |
| 09/25 | CORRECTION : Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis | GL |
| 09/25 | CORRECTION : Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis | AQ |
| 09/25 | GALAPAGOS : Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis | AQ |
| 09/25 | Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis | GL |
| 09/18 | GALAPAGOS : increases share capital through subscription right exercises | AQ |
| 09/18 | GALAPAGOS : increases share capital through subscription right exercises | AQ |
| 09/18 | Galapagos increases share capital through subscription right exercises | GL |
| 09/18 | OXURION : Business Update, H1 2020 | AQ |
| 09/15 | Oxurion NV to Present at H.C. Wainwright & Co 22nd Annual Global Investment C.. | AQ |
| 09/10 | GALAPAGOS : Primary endpoint achieved with ziritaxestat in NOVESA trial in syst.. | AQ |
| 09/10 | GALAPAGOS : Primary endpoint achieved with ziritaxestat in NOVESA trial in syst.. | AQ |
| 09/10 | Primary endpoint achieved with ziritaxestat in NOVESA trial in systemic scl.. | GL |
| 09/02 | Oxurion NV Reports First Patient Dosed in Phase 2 study evaluating THR-149 fo.. | AQ |
| 08/26 | Galapagos to present new insights in IPF and related clinical developments at.. | GL |
| 08/19 | EUROPE : Wall Street sets upbeat tone for European stocks, UK airlines jump | RE |
| 08/19 | GALAPAGOS : Gilead Shares Fall as FDA Seeks More Filgotinib Data | DJ |
| 08/19 | Gilead shares slide after FDA knocks back rheumatoid arthritis drug | RE |
| 08/19 | Wall St sets upbeat tone for European stocks, UK airlines jump | RE |
| 08/18 | GILEAD SCIENCES : Filgotinib, a Collaboration With Galapagos, Gets Complete Resp.. | DJ |
| 08/18 | Galapagos announces that Gilead received a complete response letter for filgo.. | GL |
| 08/12 | Scipher Medicine and Galapagos sign collaboration in inflammatory bowel disea.. | GL |
| 08/06 | GALAPAGOS : H1 Report 2020 | PU |
| 08/06 | Galapagos reports solid H1 2020 progress | GL |
| 07/27 | GILEAD SCIENCES : and Galapagos Announce Positive European CHMP Opinion for Jyse.. | AQ |
| 07/24 | GILEAD SCIENCES : Galapagos Say Arthritis Drug Gets Recommendation to Start Mark.. | DJ |
| 07/24 | Gilead and galapagos announce positive european chmp opinion for jys.. | GL |
| 07/24 | GALAPAGOS : Gilead and Galapagos Announce Positive European CHMP Opinion for Jys.. | BU |
| 07/13 | GILEAD SCIENCES : Pharmas restart drug trials after pandemic-related declines, M.. | RE |
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
